KCT0000329
Not yet recruiting
未知
A Multi-center, Prospective, Randomized Comparison of Circumferential Pulmonary Vein Isolation and Posterior Wall-Sparing Pulmonary Vein Isolation Techniques in Patients with Paroxysmal Atrial Fibrillation (Pilot study)
ConditionsDiseases of the circulatory system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the circulatory system
- Sponsor
- Asan Medical Center
- Enrollment
- 100
- Status
- Not yet recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients with symptomatic paroxysmal with failure of at least
- •1 antiarrhythmic drug, who were planned to ablation procedure using 3D mapping system
Exclusion Criteria
- •a. prior left atrial ablation
- •b.prior cardiac surgery
- •c.left atrial thrombus
- •d.moderate or severe mitral valve stenosis or regurgitation
- •e.left ventricular ejection fraction40%
- •f.cardiac heart failure, with a NYHA class III or IV
- •g.severe chronic obstructive pulmonary disease
- •h.contraindication to oral anticoagulation
- •i.pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Clinical study on AP/VJT/SBO Ayurvedic Hair Oil in femalesHealth Condition 1: L658- Other specified nonscarring hair lossCTRI/2022/05/042393AYURVED PRATISTHA
Not yet recruiting
Phase 4
A comparative, multicenter, prospective, randomized study to evaluate efficacy, safety and prevention of relapse with Elovera AD emollient vs plain emollient in mild to moderate atopic dermatitisHealth Condition 1: L209- Atopic dermatitis, unspecifiedCTRI/2023/03/050333Glenmark Pharmaceuticals Limited
Recruiting
Not Applicable
A multicenter, prospective, comparative, randomized, independent rater-blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software ‘SUPERBRAIN DEX’ for improving cognitive function with a control group for patients with mild cognitive impairmentMental and behavioural disordersKCT0009133Hanyang University Guri Hospital126
Completed
Phase 3
A Clinical Study to Test the Effectiveness and Side Effects of Hetero-Tenecteplase in Adult patients with Suspected Myocardial InfarctioHealth Condition 1: I213- ST elevation (STEMI) myocardial infarction of unspecified siteCTRI/2021/06/034322Hetero Biopharma Limited198
Active, not recruiting
Not Applicable
A prospective, randomized, multi-center comparative 2-arm trial on efficacy and safety of zoledronic acid every 3-months vs. every 4 weeks beyond approximately 1 year of treatment with zoledronic acid in patients with bone lesions from breast cancer - NDEUCTR2005-004942-15-ITOVARTIS FARMA420